TELIGEN Adverse Event — Injury (MDR 2124215-2020-09271)
TELIGEN Adverse Event — Injury (MDR 2124215-2020-09271) is one of 9,000 device adverse events in the DeviceEvents dataset. Key details — Device: TELIGEN; Generic name: IMPLANTABLE DEVICE; Manufacturer: BOSTON SCIENTIFIC CORPORATION.
| Device | TELIGEN |
|---|---|
| Generic name | IMPLANTABLE DEVICE |
| Manufacturer | BOSTON SCIENTIFIC CORPORATION |
| Report number | 2124215-2020-09271 |
| Event type | Injury |
| Product problem | Y |
| Date received | 2020-04-27 |
| Report source | COMPANY REPRESENTATIVE |
| Narrative | IT WAS REPORTED THAT THIS PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) HAS LONG QT SYNDROME AND FORGOT TO TAKE HIS MEDICATION WHICH CAUSED THE PATIENT TO HAVE A PANIC ATTACK. REVIEW OF THE DEVICE FOUND THAT ANTI-TACHYCARDIA PACING (ATP) WAS DELIVERED FOR VENTRICULAR TACHYCARDIA (VT) APPROPRIATELY, HOWEVER IT APPEARS THE ATP THERAPY MAY HAVE ACCELERATED THE RHYTHM TO VENTRICULAR F |
| Source | openFDA MAUDE (device adverse events) |
🔍 Search all device adverse events →
$1999/mo
Try DeviceEvents →